Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Phase 2 Dose Ranging Trial To Assess The Safety and Efficacy of DA-8159 Tablets in Male Subjects With Erectile Dysfunction.

NCT00282607 is registered in ClinicalTrials.gov with Dong-A PharmTech Co., Ltd. as lead sponsor.

NCT NCT00282607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00282607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Phase 2 Dose Ranging Trial To Assess The Safety and Efficacy of DA-8159 Tablets in Male Subjects With Erectile Dysfunction.
Lead sponsor
Dong-A PharmTech Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
June 30, 2006
Enrollment
300
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction